PRF Technologies (PRFX) Return on Assets (2021 - 2025)
PRF Technologies (PRFX) posted quarterly Return on Assets of 0.01% for Q4 2025, up 6.0% year-on-year from 0.01% in Q4 2024, and up 61.64% on a QoQ basis from 0.02% in Q2 2025.
PRF Technologies (PRFX) Return on Assets (2021 - 2025) Analysis & Trends
PRF Technologies (PRFX) has reported Return on Assets for 5 consecutive years, with 0.01% the latest figure, recorded in Q4 2025.
- Quarterly Return on Assets rose 6.0% year-over-year to 0.01% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.01% (up 6.0% YoY) and the FY2025 annual result came in at 0.01%, up 5.0% from the prior year.
- Return on Assets climbed to 0.01% in Q4 2025 per PRFX's latest filing, from 0.02% in the prior quarter.
- Over the last five years, Return on Assets for PRFX reached as high as 0.0% in Q1 2021 and fell as low as 0.07% in Q1 2024.
- A 5-year average of 0.02% and a median of 0.01% in 2022 frame the typical range for Return on Assets.
- Annual changes were most pronounced in 2024 — Return on Assets fell 6 bps — and 2025, when it gained 6 bps.
- Year by year, Return on Assets stood at 0.01% in 2021, then tumbled by 69 bps to 0.01% in 2022, then sank by 177 bps to 0.03% in 2023, then tumbled by 104 bps to 0.06% in 2024, then surged by 90 bps to 0.01% in 2025.
- According to Business Quant data, Return on Assets over the past three periods registered 0.01%, 0.02%, and 0.06% for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 0.00% |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.00% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.00% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.00% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.00% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.00% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.00% |
| 10 | PRF Technologies | 745,168.93 | 451,168.93 | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.01% |
| Jun 30, 2025 | -0.02% |
| Dec 31, 2024 | -0.06% |
| Jun 30, 2024 | -0.06% |
| Mar 31, 2024 | -0.07% |
| Dec 31, 2023 | -0.03% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |